Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition

Anna K. Dewan, Sameer Gupta, Daniel Q. Bach, Saagar Jadeja, Scott Granter, Ann LaCasce, Robin Joyce, Matthew S. Davids, Victor Huang, Nicole R. LeBoeuf

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)401-405
Number of pages5
JournalJAAD Case Reports
Volume5
Issue number5
DOIs
StatePublished - May 1 2019
Externally publishedYes

Fingerprint

1-Phosphatidylinositol 4-Kinase
Psoriasis
Immunotherapy

Keywords

  • cutaneous toxicity
  • immunotherapy
  • phosphoinositide 3-kinase inhibitors
  • psoriasis
  • small molecule inhibitors

ASJC Scopus subject areas

  • Dermatology

Cite this

Dewan, A. K., Gupta, S., Bach, D. Q., Jadeja, S., Granter, S., LaCasce, A., ... LeBoeuf, N. R. (2019). Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. JAAD Case Reports, 5(5), 401-405. https://doi.org/10.1016/j.jdcr.2018.03.005

Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. / Dewan, Anna K.; Gupta, Sameer; Bach, Daniel Q.; Jadeja, Saagar; Granter, Scott; LaCasce, Ann; Joyce, Robin; Davids, Matthew S.; Huang, Victor; LeBoeuf, Nicole R.

In: JAAD Case Reports, Vol. 5, No. 5, 01.05.2019, p. 401-405.

Research output: Contribution to journalArticle

Dewan, AK, Gupta, S, Bach, DQ, Jadeja, S, Granter, S, LaCasce, A, Joyce, R, Davids, MS, Huang, V & LeBoeuf, NR 2019, 'Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition', JAAD Case Reports, vol. 5, no. 5, pp. 401-405. https://doi.org/10.1016/j.jdcr.2018.03.005
Dewan AK, Gupta S, Bach DQ, Jadeja S, Granter S, LaCasce A et al. Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. JAAD Case Reports. 2019 May 1;5(5):401-405. https://doi.org/10.1016/j.jdcr.2018.03.005
Dewan, Anna K. ; Gupta, Sameer ; Bach, Daniel Q. ; Jadeja, Saagar ; Granter, Scott ; LaCasce, Ann ; Joyce, Robin ; Davids, Matthew S. ; Huang, Victor ; LeBoeuf, Nicole R. / Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. In: JAAD Case Reports. 2019 ; Vol. 5, No. 5. pp. 401-405.
@article{42dc171a462648cfa7c46f0b375d9c34,
title = "Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition",
keywords = "cutaneous toxicity, immunotherapy, phosphoinositide 3-kinase inhibitors, psoriasis, small molecule inhibitors",
author = "Dewan, {Anna K.} and Sameer Gupta and Bach, {Daniel Q.} and Saagar Jadeja and Scott Granter and Ann LaCasce and Robin Joyce and Davids, {Matthew S.} and Victor Huang and LeBoeuf, {Nicole R.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.jdcr.2018.03.005",
language = "English (US)",
volume = "5",
pages = "401--405",
journal = "JAAD Case Reports",
issn = "2352-5126",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition

AU - Dewan, Anna K.

AU - Gupta, Sameer

AU - Bach, Daniel Q.

AU - Jadeja, Saagar

AU - Granter, Scott

AU - LaCasce, Ann

AU - Joyce, Robin

AU - Davids, Matthew S.

AU - Huang, Victor

AU - LeBoeuf, Nicole R.

PY - 2019/5/1

Y1 - 2019/5/1

KW - cutaneous toxicity

KW - immunotherapy

KW - phosphoinositide 3-kinase inhibitors

KW - psoriasis

KW - small molecule inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85064454559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064454559&partnerID=8YFLogxK

U2 - 10.1016/j.jdcr.2018.03.005

DO - 10.1016/j.jdcr.2018.03.005

M3 - Article

AN - SCOPUS:85064454559

VL - 5

SP - 401

EP - 405

JO - JAAD Case Reports

JF - JAAD Case Reports

SN - 2352-5126

IS - 5

ER -